Literature DB >> 15248202

Biomarkers in systemic lupus erythematosus: II. Markers of disease activity.

Gabor G Illei1, Edward Tackey, Larissa Lapteva, Peter E Lipsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15248202     DOI： 10.1002/art.20345

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  44 in total

Review 1.  Biomarkers in systemic lupus erythematosus.

Authors:  Gabor G Illei; Peter E Lipsky
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 2.  Gene-expression profiling in rheumatic disease: tools and therapeutic potential.

Authors:  Jason W Bauer; Hatice Bilgic; Emily C Baechler
Journal:  Nat Rev Rheumatol       Date:  2009-05       Impact factor: 20.543

3.  Biomarkers of lupus nephritis determined by serial urine proteomics.

Authors:  Xiaolan Zhang; Ming Jin; Haifeng Wu; Tibor Nadasdy; Gyongyi Nadasdy; Nathan Harris; Kari Green-Church; Haikady Nagaraja; Daniel J Birmingham; Chack-Yung Yu; Lee A Hebert; Brad H Rovin
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

4.  Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.

Authors:  Amy H Kao; Jeannine S Navratil; Margie J Ruffing; Chau-Ching Liu; Douglas Hawkins; Kathleen M McKinnon; Natalya Danchenko; Joseph M Ahearn; Susan Manzi
Journal:  Arthritis Rheum       Date:  2010-03

5.  Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.

Authors:  Heikki Julkunen; Susanne Ekblom-Kullberg; Aaro Miettinen
Journal:  Rheumatol Int       Date:  2011-06-26       Impact factor: 2.631

6.  IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.

Authors:  Christophe Richez; Kei Yasuda; Ramon G Bonegio; Amanda A Watkins; Tamar Aprahamian; Patricia Busto; Rocco J Richards; Chih Long Liu; Regina Cheung; Paul J Utz; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 7.  [Systemic lupus erythematosus. Target criteria for treatment].

Authors:  T Alexander; R Biesen; A Jacobi; B Hoyer; A Bruns; F Hiepe
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

8.  Validity of clinical associations of biomarkers in translational research studies: the case of systemic autoimmune diseases.

Authors:  Maria G Tektonidou; Michael M Ward
Journal:  Arthritis Res Ther       Date:  2010-09-27       Impact factor: 5.156

9.  Serum growth arrest-specific protein 6 levels are a reliable biomarker of disease activity in systemic lupus erythematosus.

Authors:  Hyoun-Ah Kim; Jin-Young Nam; Ja-Young Jeon; Jeong-Mi An; Ju-Yang Jung; Chang-Bum Bae; Chang-Hee Suh
Journal:  J Clin Immunol       Date:  2012-08-23       Impact factor: 8.317

10.  Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

Authors:  Noa Schwartz; Tamar Rubinstein; Linda C Burkly; Christopher E Collins; Irene Blanco; Lihe Su; Bernard Hojaili; Meggan Mackay; Cynthia Aranow; William Stohl; Brad H Rovin; Jennifer S Michaelson; Chaim Putterman
Journal:  Arthritis Res Ther       Date:  2009-09-28       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.